Piper Sandler analyst Korinne Wolfmeyer raised the firm’s price target on Bath & Body Works to $39 from $35 and keeps an Overweight rating on the shares. The firm notes management has already flagged that Q1 sales should be at the high end of guidance, and Piper has not seen anything from April that puts that at risk. The bottom line could have less upside with investments in A&P, but the firm doesn’t believe buy side would be disappointed. As for guidance, it would not expect an increase given the macro, though management’s current 1%-3% sales growth target still looks reasonable.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- 3 Undervalued Stocks to Buy Now, 5/14/2025, According to Analysts
- Bath & Body Works price target raised to $44 from $40 at Wells Fargo
- Bath & Body Works, Inc. (BBWI) Q1 Earnings Cheat Sheet
- Clorox names Gina Boswell to its Board of Directors
- Bath & Body Works price target lowered to $31 from $38 at Barclays